Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4412203 | 1.00 | EPHX1 (0.42) | EPHX1ALDH1A1TP53DPP4SMN1; SMN2 | |
| SCHEMBL16837771 | 1.00 | EPHX1 (0.42) | EPHX1ALDH1A1TP53DPP4SMN1; SMN2 | |
| SCHEMBL503695 | 0.97 | EPHX1 (0.46) | EPHX1ALDH1A1TP53DPP4SMN1; SMN2 | |
| SCHEMBL8031276 | 0.97 | EPHX1 (0.46) | EPHX1ALDH1A1TP53DPP4SMN1; SMN2 | |
| SCHEMBL360610 | 0.97 | EPHX1 (0.46) | EPHX1ALDH1A1TP53DPP4SMN1; SMN2 | |
| SCHEMBL5686769 | 0.97 | EPHX1 (0.46) | EPHX1ALDH1A1TP53DPP4SMN1; SMN2 | |
| SCHEMBL67018 | 0.97 | EPHX1 (0.46) | EPHX1ALDH1A1TP53DPP4SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL5515976 | 0.95 | EPHX1 (0.44) | EPHX1ALDH1A1TP53DPP4SMN1; SMN2 | |
| Benzene SCHEMBL18322786 | 0.95 | EPHX1 (0.39) | EPHX1ALDH1A1TP53MAPTKDM4E | |
| SCHEMBL16837724 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026041636-A1 | MACROCYCLE COMPOUNDS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2026-02-26 | — | — | WO | disclosed |
| US-20260001876-A1 | Compounds and Their Use as PDE4 Activators | MIRONID LIMITED (GB) | 2026-01-01 | — | — | US | disclosed |
| US-20250388604-A1 | Compounds and Their Use as PDE4 Activators | MIRONID LIMITED (GB) | 2025-12-25 | — | — | US | disclosed |
| EP-4572762-A1 | COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS | Mironid Limited (GB) | 2025-06-25 | — | — | EP | disclosed |
| EP-4572761-A1 | COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS | Mironid Limited (GB) | 2025-06-25 | — | — | EP | disclosed |
| CN-119730854-A | Compounds and their use as PDE4 activators | 米罗尼德有限公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2024038129-A1 | COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS | MIRONID LIMITED (GB) | 2024-02-22 | — | — | WO | disclosed |
| WO-2024038128-A1 | COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS | MIRONID LIMITED (GB) | 2024-02-22 | — | — | WO | disclosed |
| US-6121241-A | TREATING CARDIOVASCULAR DISORDERS | GYOGYSZERKUTATO INTEZET KFT. (HU) | 2000-09-19 | — | — | US | disclosed |
| EP-0863871-B1 | ANTICOAGULANT PEPTIDE ALDEHYDE DERIVATIVES | GYOGYSZERKUTATO INTEZET (HU) | 2000-03-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001876-A1 | Compounds and Their Use as PDE4 Activators | PDE4A, PDE4B, PDE7A | EPHX1 2235/4885ALDH1A1 1240/4885TP53 4796/4885 |
| US-20250388604-A1 | Compounds and Their Use as PDE4 Activators | PDE4A, PDE7A, PDE4B | EPHX1 1796/4885ALDH1A1 989/4885TP53 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.